Pheroze Tamboli

h-index

Research activity per year

Fingerprint

Dive into the research topics where Pheroze Tamboli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

198 Article
12 Chapter
8 Review article
7 Comment/debate
More

International Society of Urological Pathology Consensus on Cancer Precursor Lesions: Working Group 3 Preneoplastic and Precursor Lesions of the Kidney
Williamson, S. R., Wobker, S. E., Mehra, R., Al-Obaidy, K. I., Martignoni, G., Mohanty, S., Smith, S. C., Tan, P. H., Tretiakova, M., Kapur, P., Wu, C. L., Akgul, M., Sangoi, A. R., Hakimi, A. A., Shuch, B., Brugarolas, J., Kristiansen, G., Cheng, L., Moch, H. & Members of the ISUP GU Cancer Precursor Consensus Panel, O. T. I. G. C. P. C. P. & 143 others, Acosta, A., Adeniran, A., Adra, N., Agarwal, N., Akgul, M., Al-Ahmadie, H., Algaba, F., Allory, Y., Al-Obaidy, K., Amin, M., Andreou, G., Barry, M., Baydar, D., Berman, D., Bezerra, S., Bremmer, F., Brugarolas, J., Brunelli, M., Bubendorf, L., Buzacott, K., Carlsen, B., Chaux, A., Chen, F., Cheng, L., Chinnaiyan, A., Choiniere, R., Cimadamore, A., Colecchia, M., Collins, K., Comperat, E., Contieri, R., Cookson, M., Cubilla, A., D’Souza, F., Dema, A., DeMarzo, A., Daugaard, G., Xavier Gomes, R. D. P., Dieckmann, K. P., Dobi, D., Downes, M., Erickson, A., Faltas, B., Fichhtner, A., Fine, S., Fleischmann, A., Fontugne, J., Ge, R., Giannarini, G., Giannico, G., Gilligan, T., Gordetsky, J., Greenland, N., Grigorescu, R., Grobholz, R., Guo, C., Gupta, S., Hallam, L., Hakimi, A., Hansel, D., Hartmann, A., Hernandez, L. H., Huang, J., Iczkowski, K., Jimenez, R., Jorda, M., Kamat, A., Kapur, P., Kaushal, S., Kench, J., Knowles, M., Kristiansen, G., Lei, L., Lele, S., Lobo, J., Loda, M., Looijenga, L., Lopez-Beltran, A., Lotan, T., Loya, A., Maclean, F., Malaviya, A., Martignoni, G., Mehra, R., Menon, S., Mertens, L., Moch, H., Mohanty, S., Montironi, R., Mühleisen, H., Necchi, A., Netto, G., Nguyen, N. N. J., Nourieh, M., Nyman, M., Oliveira, P., O’Rourke, D., Osunkoya, A., Paner, G., Meyts, E. R. D., Raspollini, M., Ratliff, T., Regauer, S., Reis, H., Riuko, O., Rodriguez-Calero, A., Ross, J., Sanchez, D., Sangoi, A., Sánta, F., Shen, S., Shuch, B., Smith, S., Spiess, P., Srigley, J., Sun, Y., Suzigan, S., Swarbrick, N., Tamboli, P., Tan, P. H., Tawil, Z., Tickoo, S., Tretiakova, M., Trias, I., True, L., Tsuzuki, T., Ulamec, M., Van der Kwast, T., van Leenders, G. J., van Rhijn, B., Lopez, F. V., Varma, M., Velazquez, E., Vescovo, M., Wang, G., Warren, A., Warrick, J., Williamson, S., Wobker, S., Wu, C. L., Ye, H., Zi, X. & Zhang, H., 2026, (Accepted/In press) In: American Journal of Surgical Pathology. 10.1097/PAS.0000000000002550.
Research output: Contribution to journal › Article › peer-review
2 Link opens in a new tab Scopus citations
Postoperative surveillance in non clear cell renal cancer: Is current practice best practice?
Das, A., Ellis, E., Tamboli, P., Rao, P., Matin, S. F., Karam, J. A. & Cotta, B., Mar 2026, In: Journal of Clinical Oncology. 44, p. 435 1 p.
Research output: Contribution to journal › Article › peer-review
Redefining the Landscape of Genitourinary Cancer Precursors: The International Society of Urological Pathology Consensus Recommendations
H.ZhangHongthe Members of ISUP GU Cancer Precursor Consensus Panel, Jun 2026, In: European urology. 89, 6, p. 483-486 4 p.
Research output: Contribution to journal › Editorial › peer-review
Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma
Moussa, M. J., Khandelwal, J., Wilson, N. R., Malikayil, K. L., Surasi, D. S., Bathala, T. K., Lin, Y., Rao, P., Tamboli, P., Sircar, K., Ajufo, H., Elsayes, K. M., Shah, A., Johns, A. C., Goswami, S., Hasanov, E., Jonasch, E., Msaouel, P., Campbell, M. T. & Alhalabi, O. & 1 others, Tannir, N. M., Feb 12 2025, In: Journal for immunotherapy of cancer. 13, 2, e010958.
Research output: Contribution to journal › Article › peer-review

Open Access
8 Link opens in a new tab Scopus citations
Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade Samples
Ruiz-Cordero, R., Wang, Q., Kumar, G., Akgul, M., Creighton, C. J., Rao, P., Tamboli, P., Zheng, L., Zhao, J., Murugan, P., Shen, S., Brimo, F., Ezhilarasan, R., Sulman, E., Wani, K., Lazar, A. J., Kim, T., Chen, K., Bhat, K. P. L. & Kannan, K. & 3 others, Wang, J., Karam, J. A. & Sircar, K., Dec 1 2025, In: European Urology Oncology. 8, 6, p. 1629-1638 10 p.
Research output: Contribution to journal › Article › peer-review

Pheroze Tamboli

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

International Society of Urological Pathology Consensus on Cancer Precursor Lesions: Working Group 3 Preneoplastic and Precursor Lesions of the Kidney

Postoperative surveillance in non clear cell renal cancer: Is current practice best practice?

Redefining the Landscape of Genitourinary Cancer Precursors: The International Society of Urological Pathology Consensus Recommendations

Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma

Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade Samples

Pheroze Tamboli

Fingerprint

Collaborations and top research areas from the last five years

Research output

International Society of Urological Pathology Consensus on Cancer Precursor Lesions: Working Group 3 Preneoplastic and Precursor Lesions of the Kidney

Postoperative surveillance in non clear cell renal cancer: Is current practice best practice?

Redefining the Landscape of Genitourinary Cancer Precursors: The International Society of Urological Pathology Consensus Recommendations

Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma

Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade Samples